Stable modifications of tegaserod hydrogen maleate

Details for Australian Patent Application No. 2004263285 (hide)

Owner Novartis AG

Inventors Pfeffer, Sabine; Vitzling, Christian

Agent Davies Collison Cave

Pub. Number AU-A-2004263285

PCT Pub. Number WO2005/014544

Priority 60/489,638 24.07.03 US

Filing date 23 July 2004

Wipo publication date 17 February 2005

International Classifications

C07D 209/14 (2006.01) Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/404 (2006.01)

Event Publications

2 February 2006 PCT application entered the National Phase

  PCT publication WO2005/014544 Priority application(s): WO2005/014544

12 February 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004263286-Novel dibenzo(B,F)oxepine-10-carboxamides and pharmaceutical uses thereof

2004263278-N- [3-(3-substituted-pyrazolo[1,5-a]pyrimidi n-7-yl)phenyl]-sulfonamides, and compositions, and methods related thereto